Venmax Drugs & Pharmaceuticals Limited has announced a board meeting to consider the financial results for the quarter and half-year.

The company provided a detailed update on its operational status, confirming continued compliance with corporate governance and financial reporting standards.

It highlighted ongoing measures to strengthen internal controls and maintain transparency.

The communication also reiterates the company’s commitment to consistent disclosure practices and investor engagement.

This assures shareholders of the company’s focus on regulatory adherence and operational integrity amid its ongoing activities.